Lubna Therachiyil
- Toxicology top 10%
- Bioactive Compounds and Antitumor Agents 2
-
- Cancer, Hypoxia, and Metabolism 5
-
- Barrier Structure and Function Studies 2
-
- Epigenetics and DNA Methylation 3
- Histone Deacetylase Inhibitors Research 3
-
- Cancer Cells and Metastasis 5
-
- Cancer, Stress, Anesthesia, and Immune Response 2
-
- Ferroptosis and cancer prognosis 2
- Co-authors
- Shahab UddinAjaz A. BhatRoopesh KrishnankuttyMuzafar A. MachaSheema HashemMohammad HarisSabah NisarSabah Akhtar
- Cited by
- ToxicologyCancer ResearchNeurology
- Journals
- PLoS ONE (1 paper)The FASEB Journal (1 paper)International Journal of Molecular Sciences (2 papers)
- Partner nations
- QatarUnited StatesIndia
In The Last Decade
Lubna Therachiyil
19 papers receiving 610 citations
Hit Papers
Peers
Comparison fields: 5 of 90
- Toxicology 28
- Cancer Research 123
- Neurology 45
- Molecular Medicine 26
- Molecular Biology 345
Countries citing papers authored by Lubna Therachiyil
This map shows the geographic impact of Lubna Therachiyil's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lubna Therachiyil with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lubna Therachiyil more than expected).
Fields of papers citing papers by Lubna Therachiyil
This network shows the impact of papers produced by Lubna Therachiyil. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lubna Therachiyil. The network helps show where Lubna Therachiyil may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Lubna Therachiyil, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2025 | 0 | |
| 3 | 2025 | 1 | |
| 4 | 2025 | 0 | |
| 5 | 2024 | 7 | |
| 6 | 2024 | 3 | |
| 7 | 2024 | 2 | |
| 8 | 2023 | 4 | |
| 9 | 2023 | 2 | |
| 10 | 2023 | 16 | |
| 11 | 2022 | 14 | |
| 12 | 2022 | 2 | |
| 13 | Targeting cancer signaling pathways by natural products: Exploring promising anti-cancer agentsbreakdown → | 2022 | 229 |
| 14 | 2020 | 18 | |
| 15 | 2020 | 32 | |
| 16 | 2020 | 103 | |
| 17 | 2020 | 31 | |
| 18 | 2018 | 47 | |
| 19 | 2017 | 35 | |
| 20 | 2016 | 1 |
About Lubna Therachiyil
Lubna Therachiyil is a scholar working on Toxicology, Cancer Research and Oncology, having authored 23 papers that have together received 619 indexed citations. Recurring topics across this work include Cancer, Hypoxia, and Metabolism (5 papers), Cancer Cells and Metastasis (5 papers), Epigenetics and DNA Methylation (3 papers), Histone Deacetylase Inhibitors Research (3 papers), Bioactive Compounds and Antitumor Agents (2 papers), Cancer, Stress, Anesthesia, and Immune Response (2 papers), Ferroptosis and cancer prognosis (2 papers) and Barrier Structure and Function Studies (2 papers). The work is most often cited by research in Toxicology (28 citations), Cancer Research (123 citations) and Neurology (45 citations). Lubna Therachiyil has collaborated with scholars based in Qatar, United States and India. Frequent co-authors include Shahab Uddin, Ajaz A. Bhat, Roopesh Krishnankutty, Muzafar A. Macha, Sheema Hashem, Mohammad Haris, Sabah Nisar, Sabah Akhtar, Geetanjali Sageena and Hesham M. Korashy. Their work appears in journals such as PLoS ONE, The FASEB Journal and International Journal of Molecular Sciences.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.